{"id":1592,"date":"2023-09-19T12:30:56","date_gmt":"2023-09-19T17:30:56","guid":{"rendered":"https:\/\/www.surfacide.com\/?p=1592"},"modified":"2023-09-20T14:16:07","modified_gmt":"2023-09-20T19:16:07","slug":"surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform","status":"publish","type":"post","link":"https:\/\/www.surfacide.com\/es\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/","title":{"rendered":"Surfacide\u00ae anuncia la distribuci\u00f3n exclusiva de PathTrac\u00ae, una plataforma de software de soporte de decisiones cl\u00ednicas de vanguardia"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><em>Los datos de PathTrac ayudan a los hospitales a prevenir las SSI antes de que ocurran mediante la identificaci\u00f3n, el monitoreo y la mejora de los protocolos de prevenci\u00f3n de infecciones en los quir\u00f3fanos<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">(Waukesha, WI y ORMC stand #926) \u2013 18 de septiembre de 2023\u2013 <a href=\"https:\/\/www.surfacide.com\/es\/\">Surfacide<\/a>, l\u00edder en tecnolog\u00eda de desinfecci\u00f3n UV-C, ha anunciado que es el socio y proveedor exclusivo de PathTrac, una innovadora plataforma de software de apoyo a la toma de decisiones cl\u00ednicas que permite a los hospitales ser m\u00e1s proactivos con sus protocolos de prevenci\u00f3n de infecciones en el quir\u00f3fano (OR).&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Al utilizar los cuatro pilares b\u00e1sicos del control de infecciones (higiene de manos, limpieza ambiental, cuidado vascular y descolonizaci\u00f3n del paciente), PathTrac mapea, informa y proporciona visibilidad de las v\u00edas asociadas con fallas en los protocolos en el quir\u00f3fano que conducen a infecciones del sitio quir\u00fargico (SSI). Con m\u00e1s de 25 estudios revisados por pares, PathTrac gu\u00eda proactivamente la mejora del quir\u00f3fano mediante la implementaci\u00f3n de intervenciones espec\u00edficas para lograr la optimizaci\u00f3n.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Las caracter\u00edsticas de PathTrac incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Monitoreo de yacimientos&nbsp;<\/li>\n\n\n\n<li>Identificaci\u00f3n de cepas bacterianas<\/li>\n\n\n\n<li>Mapeo de transmisi\u00f3n&nbsp;<\/li>\n\n\n\n<li>Kits de muestreo f\u00e1ciles de usar; el hisopo toma solo unos minutos&nbsp;<\/li>\n\n\n\n<li>Entrenamiento Virtual<\/li>\n\n\n\n<li>Base de datos y conectividad en la nube&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">&quot;Es un honor para nosotros asociarnos con RDB Bioinformatics y ser el proveedor exclusivo de PathTrac para hospitales de todo el pa\u00eds&quot;, dijo Gunner Lyslol, fundador y director ejecutivo de Surfacide. &quot;La optimizaci\u00f3n de los protocolos de higiene del quir\u00f3fano con esta importante tecnolog\u00eda prioriza la seguridad del paciente y tiene la capacidad de reducir significativamente el riesgo de SSI y HAI, que le est\u00e1n costando a la industria de la salud m\u00e1s de $6,5 mil millones cada a\u00f1o&quot;.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cEn RDB Bioinformatics, nos apasiona nuestra asociaci\u00f3n con Surfacide y que sean el conducto para llevar PathTrac a los centros de atenci\u00f3n m\u00e9dica. Tenemos un inter\u00e9s activo en las iniciativas de cada una de las empresas, mientras trabajamos juntos para desarrollar un \u00e9xito compartido para mantener a los pacientes seguros\u201d, a\u00f1adi\u00f3 el Dr. Randy Loftus, cofundador y director m\u00e9dico de RDB Bioinformatics, propietario de PathTrac.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Surfacide se enorgullece de anunciar su asociaci\u00f3n con PathTrac en la OR Manager Conference en Nashville, Tennessee, del 18 al 20 de septiembre (stand #926). Para obtener m\u00e1s informaci\u00f3n sobre las v\u00edas de transmisi\u00f3n espec\u00edficas de su quir\u00f3fano, visite nuestro stand o p\u00f3ngase en contacto con <a href=\"mailto:pathtrac@surfacide.com\">pathtrac@surfacide.com<\/a> para que un consultor de Surfacide establezca una evaluaci\u00f3n de referencia de sus instalaciones.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">V\u00eddeo de PathTrac: <a href=\"https:\/\/www.youtube.com\/watch?v=I7nOoiAqe84\">AQU\u00cd<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>PathTrac Data Helps Hospitals Pre-Empt SSI\u2019s Before They Occur By Identifying, Monitoring, and Enhancing Operating Room Infection Prevention Protocols (Waukesha, WI and ORMC Booth #926) \u2013 September 18, 2023\u2013 Surfacide, the&nbsp; leader in UV-C microbial reduction technology, has announced they are the exclusive partner and provider of PathTrac, an innovative clinical decision support software platform [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/www.surfacide.com\/es\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/\">Read More&#8230;<span class=\"screen-reader-text\"> from Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":1601,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"page-templates\/custom-blog.php","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[16],"tags":[17,23],"class_list":["post-1592","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","tag-healthcare-acute","tag-pathtrac"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform - Surfacide<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.surfacide.com\/es\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform\" \/>\n<meta property=\"og:description\" content=\"PathTrac Data Helps Hospitals Pre-Empt SSI\u2019s Before They Occur By Identifying, Monitoring, and Enhancing Operating Room Infection Prevention Protocols (Waukesha, WI and ORMC Booth #926) \u2013 September 18, 2023\u2013 Surfacide, the&nbsp; leader in UV-C microbial reduction technology, has announced they are the exclusive partner and provider of PathTrac, an innovative clinical decision support software platform [...]Read More... from Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.surfacide.com\/es\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Surfacide\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/surfacide\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-19T17:30:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-20T19:16:07+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/09\/PathTrac-Hero_OR.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1572\" \/>\n\t<meta property=\"og:image:height\" content=\"1366\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sarah Meekma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SurfacideUVC\" \/>\n<meta name=\"twitter:site\" content=\"@SurfacideUVC\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sarah Meekma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/\"},\"author\":{\"name\":\"Sarah Meekma\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/person\\\/0ccaea7fc606b91651c87ecc5a666747\"},\"headline\":\"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform\",\"datePublished\":\"2023-09-19T17:30:56+00:00\",\"dateModified\":\"2023-09-20T19:16:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/\"},\"wordCount\":357,\"publisher\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/PathTrac-Hero_OR.jpg\",\"keywords\":[\"Healthcare Acute\",\"PathTrac\"],\"articleSection\":[\"Press Release\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/\",\"name\":\"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform - Surfacide\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/PathTrac-Hero_OR.jpg\",\"datePublished\":\"2023-09-19T17:30:56+00:00\",\"dateModified\":\"2023-09-20T19:16:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/PathTrac-Hero_OR.jpg\",\"contentUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/PathTrac-Hero_OR.jpg\",\"width\":1572,\"height\":1366,\"caption\":\"Showing transmission pathways in the OR\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/blog-news\\\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.surfacide.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#website\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/\",\"name\":\"http:\\\/\\\/www.surfacide.com\",\"description\":\"Surfacide\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.surfacide.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#organization\",\"name\":\"http:\\\/\\\/www.surfacide.com\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Surfacide-logo-1.png\",\"contentUrl\":\"https:\\\/\\\/www.surfacide.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Surfacide-logo-1.png\",\"width\":263,\"height\":43,\"caption\":\"http:\\\/\\\/www.surfacide.com\"},\"image\":{\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/surfacide\",\"https:\\\/\\\/x.com\\\/SurfacideUVC\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/surfacide-llc\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.surfacide.com\\\/#\\\/schema\\\/person\\\/0ccaea7fc606b91651c87ecc5a666747\",\"name\":\"Sarah Meekma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cedb2880aefe73524c68567e26d6bbb64eff4c6ea2393a6ea873645cd64b8470?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cedb2880aefe73524c68567e26d6bbb64eff4c6ea2393a6ea873645cd64b8470?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cedb2880aefe73524c68567e26d6bbb64eff4c6ea2393a6ea873645cd64b8470?s=96&d=mm&r=g\",\"caption\":\"Sarah Meekma\"},\"url\":\"https:\\\/\\\/www.surfacide.com\\\/es\\\/blog-news\\\/author\\\/smeekma\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform - Surfacide","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.surfacide.com\/es\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/","og_locale":"es_MX","og_type":"article","og_title":"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform","og_description":"PathTrac Data Helps Hospitals Pre-Empt SSI\u2019s Before They Occur By Identifying, Monitoring, and Enhancing Operating Room Infection Prevention Protocols (Waukesha, WI and ORMC Booth #926) \u2013 September 18, 2023\u2013 Surfacide, the&nbsp; leader in UV-C microbial reduction technology, has announced they are the exclusive partner and provider of PathTrac, an innovative clinical decision support software platform [...]Read More... from Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform","og_url":"https:\/\/www.surfacide.com\/es\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/","og_site_name":"Surfacide","article_publisher":"https:\/\/www.facebook.com\/surfacide","article_published_time":"2023-09-19T17:30:56+00:00","article_modified_time":"2023-09-20T19:16:07+00:00","og_image":[{"width":1572,"height":1366,"url":"http:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/09\/PathTrac-Hero_OR.jpg","type":"image\/jpeg"}],"author":"Sarah Meekma","twitter_card":"summary_large_image","twitter_creator":"@SurfacideUVC","twitter_site":"@SurfacideUVC","twitter_misc":{"Escrito por":"Sarah Meekma","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/#article","isPartOf":{"@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/"},"author":{"name":"Sarah Meekma","@id":"https:\/\/www.surfacide.com\/#\/schema\/person\/0ccaea7fc606b91651c87ecc5a666747"},"headline":"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform","datePublished":"2023-09-19T17:30:56+00:00","dateModified":"2023-09-20T19:16:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/"},"wordCount":357,"publisher":{"@id":"https:\/\/www.surfacide.com\/#organization"},"image":{"@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/09\/PathTrac-Hero_OR.jpg","keywords":["Healthcare Acute","PathTrac"],"articleSection":["Press Release"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/","url":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/","name":"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform - Surfacide","isPartOf":{"@id":"https:\/\/www.surfacide.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/#primaryimage"},"image":{"@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/09\/PathTrac-Hero_OR.jpg","datePublished":"2023-09-19T17:30:56+00:00","dateModified":"2023-09-20T19:16:07+00:00","breadcrumb":{"@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/#primaryimage","url":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/09\/PathTrac-Hero_OR.jpg","contentUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/09\/PathTrac-Hero_OR.jpg","width":1572,"height":1366,"caption":"Showing transmission pathways in the OR"},{"@type":"BreadcrumbList","@id":"https:\/\/www.surfacide.com\/blog-news\/surfacide-announces-exclusive-distribution-of-pathtrac-a-cutting-edge-clinical-decision-support-software-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.surfacide.com\/"},{"@type":"ListItem","position":2,"name":"Surfacide\u00ae Announces Exclusive Distribution of PathTrac\u00ae, A Cutting-Edge Clinical Decision Support Software Platform"}]},{"@type":"WebSite","@id":"https:\/\/www.surfacide.com\/#website","url":"https:\/\/www.surfacide.com\/","name":"http:\/\/www.surfacide.com","description":"Surfacide","publisher":{"@id":"https:\/\/www.surfacide.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.surfacide.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.surfacide.com\/#organization","name":"http:\/\/www.surfacide.com","url":"https:\/\/www.surfacide.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.surfacide.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/06\/Surfacide-logo-1.png","contentUrl":"https:\/\/www.surfacide.com\/wp-content\/uploads\/2023\/06\/Surfacide-logo-1.png","width":263,"height":43,"caption":"http:\/\/www.surfacide.com"},"image":{"@id":"https:\/\/www.surfacide.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/surfacide","https:\/\/x.com\/SurfacideUVC","https:\/\/www.linkedin.com\/company\/surfacide-llc"]},{"@type":"Person","@id":"https:\/\/www.surfacide.com\/#\/schema\/person\/0ccaea7fc606b91651c87ecc5a666747","name":"Sara Meekma","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/cedb2880aefe73524c68567e26d6bbb64eff4c6ea2393a6ea873645cd64b8470?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/cedb2880aefe73524c68567e26d6bbb64eff4c6ea2393a6ea873645cd64b8470?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cedb2880aefe73524c68567e26d6bbb64eff4c6ea2393a6ea873645cd64b8470?s=96&d=mm&r=g","caption":"Sarah Meekma"},"url":"https:\/\/www.surfacide.com\/es\/blog-news\/author\/smeekma\/"}]}},"_links":{"self":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts\/1592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/comments?post=1592"}],"version-history":[{"count":0,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/posts\/1592\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/media\/1601"}],"wp:attachment":[{"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/media?parent=1592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/categories?post=1592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.surfacide.com\/es\/wp-json\/wp\/v2\/tags?post=1592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}